ENTITY
Celltrion

Celltrion (068270 KP)

22
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bullishCelltrion Inc
09 Feb 2018 06:22

KOSDAQ 150 Rebalancing & Celltrion Short Selling During Feb 7-8

The KRX officially said on Feb 7 that Celltrion Inc (068270 KS) would be listed on the KOSPI on Feb 9. This means there would be a massive index...

Logo
320 Views
Share
bullishCelltrion Inc
04 Feb 2018 00:10

Last Week in Event SPACE - Astellas, Celltrion, Renesas, AWE, Viva, Kushikatsu

Last week, Astellas Pharma Inc (4503 JP)'s latest buyback may impact the stock; KOSDAQ 150 names expected to benefit as Celltrion Inc (068270 KS)...

Logo
221 Views
Share
bullishCelltrion Inc
30 Jan 2018 20:45

Impact Analysis of Celltrion's KOSPI Move on KOSPI 200 and KOSDAQ 150

The KRX senior official named Lee Eun-tae had a press conference yesterday (Jan 29). He gave the major projects that the KRX is currently planning...

Logo
408 Views
Share
bullishCelltrion Inc
05 Jan 2018 12:28

Celltrion (068270 KS): Korean Making Biological Drugs for the West

Solid long-term sales growth, strong sales momentum, and high earnings quality relative to its sector Celltrion is one of Korea’s top exporters of...

Share
25 Nov 2017 21:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
508 Views
Share
x